Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 139–139 | Cite as

Cytarabine/idarubicin

Myelosuppression, agranulocytosis and fatal septicaemia: case report
Case report
  • 15 Downloads

Reference

  1. Zhao HH, et al. Efficacy observation of standard-dose IA regimen in treatment of ≥ 55 years old newly diagnosed patients with acute myeloid leukemia. [Chinese]. Journal of Leukemia and Lymphoma 26: 675-679, No. 11, Nov 2017. Available from: URL: http://doi.org/10.3760/cma.j.issn.1009-9921.2017.11.009 [Chinese: summarised from a translation] - ChinaGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations